MEXACOF-LS Junior

Description

MEXACOF-LS Junior is a pediatric oral syrup containing Levosalbutamol Sulphate I.P. equivalent to Levosalbutamol 0.5 mg, Ambroxol Hydrochloride I.P. 15 mg and Guaiphenesin I.P. 50 mg per 5 mL. The formulation combines bronchodilator, mucolytic and expectorant actions to support mucus clearance and easier breathing when prescribed for appropriate respiratory conditions.

For related pediatric respiratory formulations and other pharmaceutical products, explore the Medhexa Pharma product range for additional formulations and therapeutic segments.

Therapeutic Segment

Pediatric Respiratory Care | Cough & Cold | Bronchodilator | Mucolytic | Expectorant | Oral Syrup

Uses of MEXACOF-LS Junior

MEXACOF-LS Junior may be prescribed as part of symptomatic respiratory care when mucus congestion and airway narrowing occur together.

It may help:

• Relieve cough associated with mucus.
• Loosen and thin thick phlegm.
• Support easier expulsion of mucus from the airways.
• Provide relief from chest congestion.
• Relax airway muscles to support easier breathing.
• Provide supportive respiratory care in conditions involving bronchospasm and excessive mucus, when prescribed by a healthcare professional.

Guaifenesin is an expectorant that helps loosen phlegm and thin bronchial secretions, making coughs more productive.

Levosalbutamol, the active form of the beta-2 agonist bronchodilator class, helps relax airway smooth muscle. Related albuterol labeling describes this class as providing relief from bronchospasm in appropriate patients with reversible obstructive airway disease.

Key Benefits of MEXACOF-LS Junior

• Combines Levosalbutamol, Ambroxol Hydrochloride and Guaiphenesin in one pediatric oral syrup.
• Levosalbutamol supports bronchodilation by relaxing airway smooth muscle.
• Ambroxol supports mucus thinning and airway secretion clearance.
• Guaiphenesin helps loosen phlegm and thin bronchial secretions.
• Helps make mucus easier to expel through coughing.
• Supports relief from chest congestion.
• Helps support easier breathing when bronchospasm contributes to respiratory symptoms.
• Convenient liquid formulation for pediatric use when prescribed.
• Supplied in a 60 ML pack.

How MEXACOF-LS Junior Works

MEXACOF-LS Junior combines three ingredients with complementary respiratory actions.

Levosalbutamol acts as a beta-2 adrenergic bronchodilator. It helps relax the smooth muscles surrounding the airways, which can improve airflow when bronchospasm contributes to breathing difficulty.

Ambroxol Hydrochloride is a mucolytic that supports the reduction of mucus viscosity and helps facilitate mucus clearance from the respiratory tract.

Guaiphenesin acts as an expectorant. It helps loosen phlegm and thin bronchial secretions, allowing mucus to be cleared more effectively through coughing.

Therefore, the combination addresses two important components of mucus-producing respiratory symptoms: airway narrowing and excessive or thick mucus.

Common Side Effects of MEXACOF-LS Junior

Possible side effects may vary depending on the child, dose and underlying condition. They may include:

• Tremor or shakiness
• Headache
• Nervousness or restlessness
• Dizziness
• Nausea
• Vomiting
• Stomach discomfort
• Increased heart rate or palpitations
• Muscle cramps

Beta-2 agonist medicines can produce cardiovascular and nervous-system effects in some patients. Related albuterol labeling warns that beta-adrenergic agonists can have clinically significant cardiac effects in individual patients.

If the child develops significant palpitations, severe tremor, worsening breathing difficulty or any unusual reaction, seek medical attention promptly.

Important Safety Information

MEXACOF-LS Junior should be used only according to the product label and healthcare professional’s advice, particularly because it is intended for pediatric respiratory care.

• Do not exceed the prescribed dose.
• Use an accurate measuring device for every dose.
• Do not use a household spoon for measuring medicine.
• Do not combine with another cough, cold or bronchodilator product unless advised by a healthcare professional.
• Check other medicines for duplicate bronchodilator or expectorant ingredients.
• Inform the doctor if the child has heart disease, high blood pressure, diabetes, thyroid disease, seizures or any other significant medical condition. Related albuterol labeling specifically identifies these conditions as important to discuss with the child’s doctor.
• Seek urgent medical attention if breathing difficulty becomes severe or rapidly worsens.
• This product should not replace emergency treatment for an acute or severe asthma attack.
• Pediatric cough and cold medicines require particular care because inappropriate dosing or duplicate ingredients can cause serious adverse effects. The FDA advises following product directions carefully and consulting a healthcare professional when appropriate.
• Tell the healthcare professional about all prescription medicines, over-the-counter medicines, vitamins and supplements the child is taking.
• Keep the medicine out of reach of children.
• Do not use after the expiry date.

Dosage & Administration

Each 5 mL contains:

• Levosalbutamol Sulphate I.P. equivalent to Levosalbutamol 0.5 mg
• Ambroxol Hydrochloride I.P. 15 mg
• Guaiphenesin I.P. 50 mg

The dosage of MEXACOF-LS Junior must be determined according to the child’s age, weight, clinical condition, response to treatment and the approved product label.

Do not calculate a pediatric dose from the 60 ML bottle size.

• Shake the syrup well before use if directed on the product label.
• Measure the prescribed quantity using a suitable oral measuring device.
• Do not use a household spoon.
• Follow the prescribed frequency and duration.
• Do not increase the dose if symptoms do not improve.
• Pediatric use should remain under appropriate medical supervision.

Storage

• Store MEXACOF-LS Junior according to the conditions stated on the product label.
• Keep the bottle tightly closed when not in use.
• Protect from excessive heat, moisture and direct sunlight.
• Keep out of reach of children.
• Do not use after the expiry date.
• Follow the manufacturer’s instructions regarding storage after opening.